Sequoia Financial Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
8,918
-2,007
-18% -$45.7K ﹤0.01% 1887
2026
Q1
$234K Buy
+10,925
New +$227K ﹤0.01% 1708
2015
Q1
Sell
-3,208
Closed -$212K 187
2014
Q4
$212K Sell
3,208
-1,045
-25% -$63.8K 0.14% 143
2014
Q3
$233K Sell
4,253
-1,830
-30% -$104K 0.16% 137
2014
Q2
$354K Buy
6,083
+280
+5% +$16.5K 0.27% 89
2014
Q1
$360K Buy
5,803
+643
+12% +$37.4K 0.3% 89
2013
Q4
$275K Buy
+5,160
New +$277K 0.23% 102

Other funds holding MD

Sequoia Financial Advisors's MD Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Pediatrix Medical (MD) stake by 18% in Q2 2026, selling an estimated $45.7K and leaving 8,918 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Sequoia Financial Advisors first reported a position in MD in Q4 2013 and has held it in 7 quarters since. The position peaked at $360K in Q1 2014. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Sequoia Financial Advisors held 8,918 shares of Pediatrix Medical worth $226K as of Q2 2026.
  • Sequoia Financial Advisors sold 2,007 Pediatrix Medical shares in Q2 2026, an estimated $45.7K.
  • Pediatrix Medical made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1887 holding.
  • Sequoia Financial Advisors first reported a position in Pediatrix Medical in Q4 2013 and has held it in 7 quarters since.
  • Sequoia Financial Advisors's Pediatrix Medical position peaked at $360K in Q1 2014.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.